Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 49

EClinicalMedicine

Among high-risk patients with mild to moderate COVID-19, casirivimab–imdevimab treatment was associated with a significantly lower rate of